Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Plinabulin, a Novel Small Molecule in Development for Chemotherapy-Induced-Neutropenia (CIN) Prevention, Mobilizes CD34+Cells through a Mechanism of Action (MoA) Different from G-CSF and from CXCR4 Inhibition Blayney, D. W., Ette, E., Ogenstad, S., Shi, Y., Du, L., Lloyd, K., Huang, L., Mohanlal, R. AMER SOC HEMATOLOGY. 2018
View details for DOI 10.1182/blood-2018-99-113569
View details for Web of Science ID 000454837606061